跳至主要内容
临床试验/NCT01048398
NCT01048398已完成3 期

Remifentanil Versus Placebo for Pain Treatment External Cephalic Versions. Randomized, Controlled and Masked

Basque Health Service1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2010年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Degree of decrease in pain experienced by patients during the maneuver according to the VAS

研究概览

简要总结

BACKGROUND: Between 3-4% of pregnancies carried to term, the fetuses are in breech presentation. The external version is a maneuver gynecological used to turn a breech in cephalic presentation. For treatment of pain suggests the use of μ agonist remifentanil for fast action and elimination.

OBJECTIVE: To compare the effectiveness of remifentanil for pain management in external version.

PATIENTS: Pregnant for 36 weeks or more with breech presentation who met the inclusion criteria and sign the consent. Participants will be randomized into two groups before the procedure.

Group intervention: paracetamol and remifentanil Control group: paracetamol and placebo DETERMINATIONS: VAS pain level, percentage of success of the maneuver and adverse events.

Statistical Analysis: Comparison of pain recorded by VAS in both groups and comparison of adverse events

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Fetuses between weeks 36 and 41 of gestation confirmed by ultrasound with non-cephalic presentation.
  • Informed consent signed by the mother or legal representative in his absence.

排除标准

  • Fetal anomalies
  • Severe hypertension
  • Allergy to drug used in the test
  • Amniotic fluid index ≥ 5 cm
  • Contraindication for vaginal delivery
  • Uterine abnormality and impaired coagulation
  • Placenta previa
  • Rh sensitization
  • Multiple gestation
  • Ruptured membranes
  • Premature detachment of normally inserted placenta
  • The mother greater weight to 85kg

研究组 & 干预措施

Remifentanil

Experimental

干预措施: remifentanil (Drug)

Paracetamol

Active Comparator

intravenous paracetamol 1g

干预措施: paracetamol (Drug)

结局指标

主要结局

Degree of decrease in pain experienced by patients during the maneuver according to the VAS

时间窗: 10 minutes

次要结局

  • Proportion of patients in each group in which the procedure is effective and avoids performing a Caesarean section.(1 day)
  • Number of adverse events and severity(1 day)

研究者

发起方
Basque Health Service
申办方类型
Other Gov

研究点 (1)

Loading locations...

相似试验